Inovio prices $30M public offering of 10M shares and warrants

INOVIO PHARMACEUTICALS, INC.

10M shares at $3.00/share plus warrants to buy 10M shares at $3.76, 5-year term.
Gross proceeds $30M; net proceeds ~$27.6M after discounts and expenses.
Closing expected December 16, 2024, subject to customary conditions.
Warrants include 4.99% beneficial ownership limitation (up to 9.99% on election).
Oppenheimer & Co. and Citizens JMP joint book-runners; Stephens Inc. lead manager.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.